Orexo US, Inc., a prominent player in the pharmaceutical industry, is headquartered in the United States and operates extensively across North America. Founded in 1995, the company has established itself as a leader in developing innovative treatments for opioid dependence and pain management. Orexo is renowned for its unique drug delivery systems, particularly its sublingual formulations that enhance patient compliance and therapeutic outcomes. With a strong focus on addressing unmet medical needs, Orexo has achieved significant milestones, including the successful launch of its flagship product, Zubsolv, which has garnered recognition for its effectiveness in treating opioid use disorder. The company’s commitment to research and development positions it favourably in the competitive landscape, making Orexo US, Inc. a key contributor to advancements in addiction treatment and pain relief solutions.
We don't have data for Orexo Us, Inc., but we can show you information about their parent organization instead.
View parent company